Skip to content

Medical-device intelligence

BioMerieux SA: FDA clearances and recalls

Research BioMerieux SA in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

0 clearance records and 46 recall records in the covered releases, across 1 source company names and 20 product codes. Dated history runs from Apr 17, 2013 to Sep 11, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202601
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

46 matching records
Device / recordCompany in FDA recordSourceSource date
EMAG system Model/Catalog Number: 418591/418591U Product Description: Nucleic acid sample preparation instrument IVD, automatedZ-0301-2027 · JJHBioMerieux SARecallOct 27, 2026FDA classification date
MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO SystemZ-0084-2022 · OUGBioMerieux SARecallOct 8, 2021FDA record creation date
MYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission of results by transferring, storing,…Z-2225-2021 · N/ABioMerieux SARecallAug 6, 2021FDA record creation date
NucliSENS Magnetic Extraction ReagentsZ-0218-2019 · PPMBioMerieux SARecallOct 23, 2018FDA record creation date
VIDAS FSH, Ref 30407-01, IVD, Rx. The firm name on the label is bioMerieux SA, France. For use on the instruments of the VIDAS family (VITEK Im…Z-2331-2018 · CGJBioMerieux SARecallJun 29, 2018FDA classification date
The VITEK 2 Gram-Positive identification card (GP) is intended for use with the VITEK 2 Systems for the automated identification of most signific…Z-2164-2018 · LQLBioMerieux SARecallJun 12, 2018FDA record creation date
The VITEK 2 Neisseria-Haemophilus identification card (NH) is intended for use with the VITEK 2 Systems for the automated identification of most …Z-2165-2018 · JSTBioMerieux SARecallJun 12, 2018FDA record creation date
The VITEK 2 Anaerobic and Corynebacteria identification card (ANC) is intended for use with the VITEK 2 Systems for the automated identification …Z-2166-2018 · JSPBioMerieux SARecallJun 12, 2018FDA record creation date
The VITEK 2 Gram Positive Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determ…Z-2167-2018 · LONBioMerieux SARecallJun 12, 2018FDA record creation date
The VITEK 2 Gram Negative Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determ…Z-2168-2018 · LONBioMerieux SARecallJun 12, 2018FDA record creation date
VIDAS TOXO IgG Avidity is an automated qualitative test for use on the VIDAS family instruments, for the determination of anti-toxoplasma IgG avi…Z-2169-2018 · LGDBioMerieux SARecallJun 12, 2018FDA record creation date
The PREVI Color Gram dyes are used with the PREVI Color Gram instrument to stain bacterial and fungal microorganisms for direct examination, acco…Z-2170-2018 · KPABioMerieux SARecallJun 12, 2018FDA record creation date
Color Gram 2 (COLOR GRAM 2 - F), these stains are used to stain bacterial and fungal microorganisms for direct examination, according to the Gram…Z-2171-2018 · JTSBioMerieux SARecallJun 12, 2018FDA record creation date
Oxidase Reagent (ref: 55635): This test is used to detect the production of the enzyme cytochrome oxidase by bacteria. This enzyme is characteris…Z-2172-2018 · JTOBioMerieux SARecallJun 12, 2018FDA record creation date
ETEST OXACILLIN OX 256 US F100 In vitro diagnostic, a quantitative technique for determining the antimicrobial susceptibility of bacteria spe…Z-0264-2018 · JWYBioMerieux SARecallDec 19, 2017FDA classification date
ETEST OXACILLIN OX 256 WW F100 In vitro diagnostic, a quantitative technique for determining the antimicrobial susceptibility of bacteria spec…Z-0265-2018 · JWYBioMerieux SARecallDec 19, 2017FDA classification date
NucliSENS Lysis Buffer Extended lot for RES 76675Z-0086-2018 · PPMBioMerieux SARecallNov 9, 2017FDA record creation date
ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a quantitative technique for determining the antimicrobial susceptibility…Z-2095-2017 · JWYBioMerieux SARecallMay 3, 2017FDA classification date
Ceftriaxone TX 32 US S30, Ref 412302 and Ceftriaxone TX 32 US F100, Ref 507058 ETEST is a quantitative technique for determining the antimicro…Z-2126-2017 · JWYBioMerieux SARecallMay 3, 2017FDA classification date
ETEST Ceftazidime TZ256 Foam packaging, Product Name: ETEST Ceftazidime TZ 0.016-256. ETEST is a quantitative technique for determining the antim…Z-1521-2017 · JWYBioMerieux SARecallMar 21, 2017FDA classification date
ETEST Cephalotin CE 256 Foam packaging, Product Name: ETEST Cephalothin CE 0.016-256. ETEST is a quantitative technique for determining the antim…Z-1522-2017 · JWYBioMerieux SARecallMar 21, 2017FDA classification date
ETEST Ceftriaxone TXL32 SPB, Product Name: ETEST Ceftriaxone TX 0.002-32(low). ETEST is a quantitative technique for determining the antimicrobia…Z-1523-2017 · JWYBioMerieux SARecallMar 21, 2017FDA classification date
Ciprofloxacin CI 32 Foam packaging, Product Name: ETEST Ciprofloxacin CI 0.002-32. ETEST is a quantitative technique for determining the antimicr…Z-1524-2017 · JWYBioMerieux SARecallMar 21, 2017FDA classification date
ETEST Vancomycin VA 256 FOAM packaging, Product Name: ETEST Vancomycin VA 0.016-256. ETEST is a quantitative technique for determining the antimi…Z-1525-2017 · JWYBioMerieux SARecallMar 21, 2017FDA classification date
ETEST Doripenem DOR32 FOAM packaging, Product Name: Etest Doripenem DOR 0.002-32. ETEST is a quantitative technique for determining the antimicr…Z-1526-2017 · JWYBioMerieux SARecallMar 21, 2017FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗